Cargando…
Review of 11 national policies for rare diseases in the context of key patient needs
Rare diseases collectively exert a global public health burden in the severity of their manifestations and the total number of people they afflict. For many patients, considerable barriers exist in terms of access to appropriate care, delayed diagnosis and limited or non-existing treatment options....
Autores principales: | Dharssi, Safiyya, Wong-Rieger, Durhane, Harold, Matthew, Terry, Sharon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374691/ https://www.ncbi.nlm.nih.gov/pubmed/28359278 http://dx.doi.org/10.1186/s13023-017-0618-0 |
Ejemplares similares
-
State of the art of rare disease activities around the world: overview of the non-European landscape
por: Wong-Rieger, Durhane
Publicado: (2012) -
Developing a Patient-Directed Policy Framework for Managing Orphan and Ultra-Orphan Drugs Throughout Their Lifecycle
por: Menon, Devidas, et al.
Publicado: (2015) -
Essential list of medicinal products for rare diseases: recommendations from the IRDiRC Rare Disease Treatment Access Working Group
por: Gahl, William A., et al.
Publicado: (2021) -
National health policy: Need to innovate
por: Patwardhan, Bhushan
Publicado: (2015) -
Rare diseases in Tanzania: a National Call for Action to address policy and urgent needs of individuals with rare diseases
por: Kaywanga, Frida, et al.
Publicado: (2022)